Sage's oral postpartum depression treatment succeeds in late-stage study

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

REUTERS: Sage Therapeutics Inc said on Monday its oral treatment for postpartum depression met the main goal of reducing symptoms of the ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Allergan's add-on treatment for depression fails late-stage studiesAllergan Plc said on Wednesday its experimental add-on treatment for major depressive disorder failed to meet the main goals of three late-stage ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lilly's combo therapy succeeds in late-stage lung cancer studyEli Lilly and Co said on Tuesday that its combo treatment, Cyramza, met the main goal in a late-stage study in patients with a form of lung cancer.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

ImmunoGen's ovarian cancer drug fails in late-stage studyREUTERS: U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Merck's Keytruda fails late-stage study in liver cancer patientsMerck & Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AstraZeneca's Lynparza meets main goal of late-stage cancer studyBritish drugmaker AstraZeneca Plc said on Tuesday its cancer drug being jointly developed with U.S.-based Merck & Co met the primary goal in a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Alnylam's gene-silencing drug meets main goal in late-stage studyREUTERS: Alnylam Pharmaceuticals Inc said on Wednesday its gene-silencing drug for treating a rare, painful disease met the main goal in a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AbbVie's cancer drug fails to meet main goal in late-stage studyREUTERS: AbbVie Inc said on Friday its cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »